PrEP and HIV Prevention in Pregnant Persons
- Describe risk factors for HIV acquisition
- Describe HIV prevention methods
- Describe pre-exposure prophylaxis that can be used in pregnant persons who are vulnerable to HIV
- Implement and incorporate HIV prevention methods, including PrEP, into the care of pregnant persons who are vulnerable to HIV
Continuing Medical Education (CME): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Pittsburgh School of Medicine and MidAtlantic AIDS Education and Training Center. The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing: The MidAtlantic AIDS Education and Training Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association Approver Unit an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This event is eligible for 1.0 credit hours.
Certificate of Attendance
Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s).
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Funding for this presentation was made possible in part by U1OHA29295 from the Health Resources and Services Administration HIV/AIDS Bureau. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only.
The information presented at this program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Anyone who works with pregnant persons
A variety of the listed topics will be discussed at this event.
- Pre-exposure prophylaxis (PrEP)
- Prevention of perinatal or mother-to-child transmission
- Reproductive health, including preconception planning